Folic acid antagonists pemetrexed
Heinzl, S.
Medizinische Monatsschrift für Pharmazeuten 27(7): 220-222
2004
ISSN/ISBN: 0342-9601 PMID: 15296355 Document Number: 567372
Document emailed within 1 workday
Related Documents
Randazzo, S.D.; Mirone, A.; Giardina, A.; Guarneri, B. 1972: On special methods of use of folic acid antagonists in psoriasis Giornale Italiano di Dermatolotia. Minerva Dermatologica 47(4): 151-155Loo, T.L.; Johns, D.G.; Farquhar, D. 1973: Recent advances in the biochemical pharmacology of folic acid antagonists Transplantation Proceedings 5(3): 1161-1165
Reich, E.W.; Cox, R.P.; Becker, M.H.; Genieser, N.B.; McCarthy, J.G.; Converse, J.M. 1978: Recognition in adult patients of malformations induced by folic-acid antagonists Birth Defects Original Article Series 14(6b): 139-160
Champel, V.; Radal, M.; Moulin-Vallez, M.; Jonville-Béra, A.P.; Autret-Leca, E. 1999: Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy Revue Neurologique (Paris) 155(3): 220-224
Marsh, J.C. 1982: Comparative effects of methotrexate, two nonclassic folic acid antagonists, and cytarabine on hematopoietic precursor cells Cancer Treatment Reports 66(3): 499-504
Kihlberg, R. 1995: Folic acid prevents neural tube defects. All women of fertile age should increase their intake of folic acid Lakartidningen 92(6): 508-512
Gerzeli, G.; Nano, R.; Marini, G. 1979: Histochemical demonstration of tetrahydrofolate dehydrogenase in human bone marrow: apparent enzymatic induction after administration of folic acid antagonists Bollettino della Societa Italiana di Biologia Sperimentale 55(6): 590-596
Levy, A.; Matok, I.; Gorodischer, R.; Sherf, M.; Wiznitzer, A.; Uziel, E.; Koren, G. 2012: Bias toward the null hypothesis in pregnancy drug studies that do not include data on medical terminations of pregnancy: the folic acid antagonists Journal of Clinical Pharmacology 52(1): 78-83
Jiang, Y.; Li, C.; Ma, Y.; Chen, J.; Li, Y.; Chen, L. 2012: The Inhibition of the Pemetrexed-Activated MAPK Pathway via Sorafenib is Involved in the Synergistic Mechanism of Sorafenib Subsequent Potentiation of Pemetrexed Cytotoxicity in EGFR TKI-Resistant Cell Lines Clinical Laboratory 58(5-6): 551-561
Mazure, P.A. 1996: Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA) Acta Gastroenterologica Latinoamericana 26(4): 263-265
Suckewer, A. 1970: The effect of ascorbic acid on the results of the estimation of folic acid in food products Roczniki Panstwowego Zakladu Higieny 21(1): 45-53
Loh, H.S.; Dempsey, P.M. 1974: Ascorbic acid, folic acid inter-relationships in geriatric subjects Journal of the Irish Medical Association 67(9): 247-250
Ferkany, J.W.; Slevin, J.T.; Zaczek, R.; Coyle, J.T. 1982: Failure of folic acid derivatives to mimic the actions of kainic acid in brain in vitro or in vivo Neurobehavioral Toxicology and Teratology 4(5): 573-579
Ortiz, Z.; Shea, B.; Suarez-Almazor, M.E.; Moher, D.; Wells, G.A.; Tugwell, P. 1998: The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials Journal of Rheumatology 25(1): 36-43
Diez-Ewald, M. 2000: Why folic acid? Investigacion Clinica 41(1): 1-2
Hayden, M.R. 2003: New use for folic acid Missouri Medicine 100(1): 14-15
Ströhle, A.; Wolters, M.; Hahn, A. 2015: Safety of folic acid Medizinische Monatsschrift für Pharmazeuten 38(8): 297-306; Quiz: 307-308
Millar, W.J. 2004: Folic acid supplementation Health Reports 15(3): 49-52
Senarath Yapa, R.S. 1988: Folic acid therapy dangers Practitioner 232(1454): 987
Vaintrub, M.I. 1987: Folic acid treatment of epileptics Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(6): 866-870